Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Demant A/S is a company specializing in hearing healthcare solutions. It operates in the medical technology industry, providing hearing aids, audiometric equipment, and hearing implants. The company also offers personal communication solutions and hearing care services through its retail network. Founded in 1904 and headquartered in Smørum, Denmark, Demant has a significant presence in Europe, North America, and other regions, serving users worldwide. The company's strategic positioning is strengthened by its focus on R&D and innovation, which supports its diverse product portfolio and ability to meet various customer needs in the hearing health market.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Demant A/SEli Lilly
Last price
€45.53$1,427.28
Currency
EUR
USD
€10B$1.3T
48.5046.65
€1.02$30.81
0.760.39
0$6.69
00.48%
Sector
HealthHealth
Employees
26,61650,000
Ticker
€DEMANT$LLY
Primary listing
XGATNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €DEMANT or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.